Update on fertility preservation from the Barcelona International Society for Fertility Preservation–ESHRE–ASRM 2015 expert meeting: indications, results.

Slides:



Advertisements
Similar presentations
Collection of testicular tissue for fertility preservation in young boys Harold BOURNE 1,2, Debra GOOK 1,2, Janell ARCHER 1,2, Hayley FISHER-STAMP 1,2,
Advertisements

Solutions to Infertility Reproductive Technologies.
Fertility preservation for girls - current treatment options Dr Sheila Lane July 8 th 2016.
Evaluation of cryopreserved ovarian tissue from prepubertal patients after long-term xenografting and exogenous stimulation  Valérie Luyckx, M.D., Sarah.
Fertility preservation in pre-pubertal girls with cancer: the role of ovarian tissue cryopreservation  W. Hamish B. Wallace, M.D., Thomas W. Kelsey, Ph.D.,
Clinical outcome of non–hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome  Michel De Vos,
What is a difficult transfer
Stem cell therapeutic possibilities: future therapeutic options for male-factor and female- factor infertility?  Charles A. Easley, Calvin R. Simerly,
Fertility preservation in pre-pubertal girls with cancer: the role of ovarian tissue cryopreservation  W. Hamish B. Wallace, M.D., Thomas W. Kelsey, Ph.D.,
Adenomyosis does not affect implantation, but is associated with miscarriage in patients undergoing oocyte donation  José A. Martínez-Conejero, Ph.D.,
Monitoring the ovaries after autotransplantation of cryopreserved ovarian tissue: endocrine studies, in vitro fertilization cycles, and live birth  Dror.
Mara Curaba, M. Sc. , Magali Verleysen, M. D
Cryopreservation of ovarian tissue for fertility preservation: no evidence of malignant cell contamination in ovarian tissue from patients with breast.
Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience  Kutluk Oktay, M.D.,
Marie-Madeleine Dolmans, M. D. , Ph. D. , Valérie Luyckx, M. D
Chick embryo chorioallantoic membrane (CAM) model: a useful tool to study short-term transplantation of cryopreserved human ovarian tissue  Belen Martinez-Madrid,
Vitrification and xenografting of human ovarian tissue
Four spontaneous pregnancies and three live births following subcutaneous transplantation of frozen banked ovarian tissue: What is the explanation?  Kutluk.
In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation 
Zhi-Yong Yang, M.D., Ri-Cheng Chian, Ph.D.  Fertility and Sterility 
Volume 17, Issue 3, Pages (September 2015)
Fertility preservation and refreezing of transplanted ovarian tissue—a potential new way of managing patients with low risk of malignant cell recurrence 
Live birth after allografting of ovarian cortex between monozygotic twins with Turner syndrome (45,XO/46,XX mosaicism) and discordant ovarian function 
Kathrin Gassei, Ph.D., Kyle E. Orwig, Ph.D.  Fertility and Sterility 
Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone–stratified, dose–response trial in women undergoing.
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.
Shi Ying Jin, Ph. D. , Lei Lei, Ph. D. , Ariella Shikanov, Ph. D
Mikkel Rosendahl, M. D. , Claus Yding Andersen, D. M. Sc
Oocyte cryopreservation
Pup birth from mouse oocytes in preantral follicles derived from vitrified and warmed ovaries followed by in vitro growth, in vitro maturation, and in.
S. Hendriks, E. A. F. Dancet, A. Meissner, F. van der Veen, M. H
The next (re)generation of ovarian biology and fertility in women: is current science tomorrow's practice?  Dori C. Woods, Ph.D., Jonathan L. Tilly, Ph.D. 
Do anti-mullerian hormone levels predict ovarian reserve in SLE patients presenting for hematopoietic stem cell transplant?  H. Browne, A. Armstrong,
Six years' experience in ovum donation using vitrified oocytes: report of cumulative outcomes, impact of storage time, and development of a predictive.
With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice?  Jacques Donnez, M.D., Ph.D., Olivier.
Cumulative live-birth rates per total number of embryos needed to reach newborn in consecutive in vitro fertilization (IVF) cycles: a new approach to.
Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation  Jacques Donnez,
I. Dimitriadis, G. Y. Christou, K. A. Dickinson, M. Thatcher, C. L
Improving the Reporting of Clinical Trials of Infertility Treatments (IMPRINT): modifying the CONSORT statement    Fertility and Sterility  Volume 102,
A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin.
Germline stem cells: toward the regeneration of spermatogenesis
Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic.
Immunohistochemical localization of growth factors after cryopreservation and 3 weeks' xenotransplantation of human ovarian tissue  Anu David, M.Sc.,
Pathogenesis of uterine adenomyosis: invagination or metaplasia?
Ana Cobo, Ph. D. , Juan A. García-Velasco, M. D. , Aila Coello, Ph. D
Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysis  Aylin Pelin Cil, M.D., Heejung Bang, Ph.D.,
Nondominant small follicles are a promising source of mature oocytes in modified natural cycle in vitro fertilization and embryo transfer  Shokichi Teramoto,
Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic.
Evaluation of diagnostic testis biopsy and the repetition of testicular sperm extraction surgeries in infertility patients  Alayman Hussein, M.B.B.C.H.,
Current approach to fertility preservation by embryo cryopreservation
Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities.
Live babies born per oocyte retrieved in a subpopulation of oocyte donors with repetitive reproductive success  J. Ryan Martin, M.D., Jason G. Bromer,
Ri-Cheng Chian, Ph.D., Peter S. Uzelac, M.D., Geeta Nargund, M.D. 
Roberto Ensenat-Waser, Ph. D. , Antonio Pellicer, M. D. , Ph. D
S. Samuel Kim, M.D.  Fertility and Sterility 
Adult somatic cells to the rescue: nuclear reprogramming and the dispensability of gonadal germ cells  Charles A. Easley, Ph.D., David R. Latov, Calvin.
Emergency IVF versus ovarian tissue cryopreservation: decision making in fertility preservation for female cancer patients  Karine Chung, M.D., M.S.C.E.,
Yohei Hayashi, Ph. D. , Mitinori Saitou, M. D. , Ph. D
James M. Hotaling, M. D. , M. S. , Natalya A. Lopushnyan, M. D
Clinical and biologic evaluation of ovarian function in women treated by bone marrow transplantation for various indications during childhood or adolescence 
Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection.
Jacques Donnez, M. D. , Ph. D. , Jean Squifflet, M. D
Genetic evaluation procedures at sperm banks in the United States
Variability in testis biopsy interpretation: implications for male infertility care in the era of intracytoplasmic sperm injection  Matthew R. Cooperberg,
David H. Barad, M.D., M.S., Norbert Gleicher, M.D. 
Multiple fertility preservation approach in cancer patients: IVF and embryo freezing using donor or husband sperm combined with oocyte cryopreservation.
Which patients pursue fertility preservation treatments
Fertility Preservation in Breast Cancer
Tamer M. Said, M. D. , Geetha Ranga, M. D. , Ashok Agarwal, Ph. D. , H
Ernesto Bosch, M. D. , Elena Labarta, M. D
Presentation transcript:

Update on fertility preservation from the Barcelona International Society for Fertility Preservation–ESHRE–ASRM 2015 expert meeting: indications, results and future perspectives  Francisca Martinez Claus Yding Andersen, P.N. Barri, Robert Brannigan, A. Cobo, Jacques Donnez, Marie Madeleine Dolmans, J.L.H. (Hans) Evers, Anis Feki, Mariëtte Goddijn, Clarisa Gracia, Sam Kim, Francisca Martinez, Dror Meirow, Pasquale Patrizio, Antonio Pellicer, Helen Picton, Mitchel Rosen, Petra de Sutter, Anna Veiga, Hamish Wallace Francisca Martinez Claus Yding Andersen, P.N. Barri, Robert Brannigan, A. Cobo, Jacques Donnez, Marie Madeleine Dolmans, J.L.H. (Hans) Evers, Anis Feki, Mariëtte Goddijn, Clarisa Gracia, Sam Kim, Francisca Martinez, Dror Meirow, Pasquale Patrizio, Antonio Pellicer, Helen Picton, Mitchel Rosen, Petra de Sutter, Anna Veiga, Hamish Wallace  Fertility and Sterility  Volume 108, Issue 3, Pages 407-415.e11 (September 2017) DOI: 10.1016/j.fertnstert.2017.05.024 Copyright © 2017 The Authors Terms and Conditions

Figure 1 Algorithm for the cryopreservation of testicular tissue/sperm in pre-pubertal and adolescent patients at high risk of infertility. Clinical assessment for puberty should be carried out by a clinician with experience in pubertal assessment. It must be stressed that no clinical parameter can accurately predict the presence of sperm. The proven treatment option for pubertal and adolescent boys who are considered capable of producing a semen sample is semen collection and cryopreservation. If sufficient sperm are recovered, the gametes can be banked using commercial glycerol-based sperm cryomedia. For those young patients who are clinically pre-pubertal and for whom semen cryopreservation is not possible, the fertility preservation strategy should include collection of a testicular biopsy by an experienced surgeon. The tissue should be cryopreserved with a protocol optimised for preserving immature germ cells, (immature testis protocol). Patients who are pubertal but are unable to produce a suitable semen sample may proceed to testicular biopsy, with intra-operative analysis. Techniques for intra-operative analysis may vary between institutions but should be aimed at identifying tissue containing (or likely to contain) sperm. This should be carried out by an individual with experience in analysis of testicular tissue (e.g. surgeon, embryologist or andrologist). When sperm are not identified or deemed unlikely the tissue should be frozen with the immature testis protocol used for pre-pubertal patients. For patients in whom sperm are identified or considered likely to be present, tissue should be split into two portions for storage. One portion should be cryopreserved using the immature testis preservation protocol, while the second portion should be stored using a protocol aimed at preserving mature sperm cells with glycerol as the main cryoprotectant. As stated in the text, at present there are several protocols for cryopreservation of immature testicular tissue and there is no clear evidence at the time of writing to demonstrate which is optimal. Reprinted with permissions from (2). Fertility and Sterility 2017 108, 407-415.e11DOI: (10.1016/j.fertnstert.2017.05.024) Copyright © 2017 The Authors Terms and Conditions

Figure 2 Fertility preservation techniques in women. Experimental procedures are indicated in discontinuous boxes, while established ones (i.e. those proven to restore fertility, with live births reported) are indicated in shaded boxes. Vitrified-thawed oocytes can be fertilized by IVF/ICSI for embryo transfer. Immature oocytes can be matured in vitro (IVM) for IVF/ICSI. Research is undergoing on the potential use of oogonial stem cells to repopulate follicle-depleted ovaries or differentiating follicle somatic cells and oocytes from embryonic stem cells or induced pluripotent stem cells to assemble de novo follicles for transplantation or IVM and IVF/ICSI. *Cryopreserved. OT = ovarian tissue. Fertility and Sterility 2017 108, 407-415.e11DOI: (10.1016/j.fertnstert.2017.05.024) Copyright © 2017 The Authors Terms and Conditions

Figure 1 Algorithm for the cryopreservation of testicular tissue/sperm in pre-pubertal and adolescent patients at high risk of infertility. Clinical assessment for puberty should be carried out by a clinician with experience in pubertal assessment. It must be stressed that no clinical parameter can accurately predict the presence of sperm. The proven treatment option for pubertal and adolescent boys who are considered capable of producing a semen sample is semen collection and cryopreservation. If sufficient sperm are recovered the gametes can be banked using commercial glycerol-based sperm cryomedia. For those young patients who are clinically pre-pubertal and for whom semen cryopreservation is not possible the fertility preservation strategy should include collection of a testicular biopsy by an experienced surgeon. The tissue should be cryopreserved with a protocol optimized for preserving immature germ cells, (immature testis protocol). Patients who are pubertal but are unable to produce a suitable semen sample may proceed to testicular biopsy, with intra-operative analysis. Techniques for intra-operative analysis may vary between institutions but should be aimed at identifying tissue containing (or likely to contain) sperm. This should be carried out by an individual with experience in analysis of testicular tissue (e.g. surgeon, embryologist or andrologist). When sperm are not identified or deemed unlikely the tissue should be frozen with the immature testis protocol used for pre-pubertal patients. For patients in whom sperm are identified or considered likely to be present, tissue should be split into two portions for storage. One portion should be cryopreserved using the immature testis preservation protocol, whilst the second portion should be stored using a protocol aimed at preserving mature sperm cells with glycerol as the main cryoprotectant. As stated in the text at present there are several protocols for cryopreservation of immature testicular tissue and there is no clear evidence at the time of writing to demonstrate which is optimal. Reprinted with permission from (7). Fertility and Sterility 2017 108, 407-415.e11DOI: (10.1016/j.fertnstert.2017.05.024) Copyright © 2017 The Authors Terms and Conditions

Figure 2 Fertility preservation techniques in women. Experimental procedures are indicated in discontinuous boxes, while established ones (i.e. those proven to restore fertility, with live births reported) are indicated in shaded boxes. Vitrified-thawed oocytes can be fertilized by IVF/ICSI for embryo transfer. Immature oocytes can be matured in vitro (IVM) for IVF/ICSI. Research is undergoing on the potential use of oogonial stem cells to repopulate follicle-depleted ovaries or differentiating follicle somatic cells and oocytes from embryonic stem cells or induced pluripotent stem cells to assemble de novo follicles for transplantation or IVM and IVF/ICSI. *Cryopreserved. OT = ovarian tissue. Fertility and Sterility 2017 108, 407-415.e11DOI: (10.1016/j.fertnstert.2017.05.024) Copyright © 2017 The Authors Terms and Conditions